Cardiothoracic
From the Journals
More fatalities in heart transplant patients with COVID-19
FDA/CDC
FDA okays emergency use for Impella RP in COVID-19 right heart failure
Conference Coverage
To fast or not to fast before elective cardiac catheterization
From the Journals
Repeat TAVR outcomes ‘reassuring’
Conference Coverage
Substantial very late MACE risk after PCI for SIHD
Analysis of 19 prospective randomized coronary stent trials finds no plateau in MACE beyond first year.
From the Journals
Consensus recommendations on AMI management during COVID-19
The ACC, ACEP, and SCAI recommend a systematic approach for the care of patients with an acute myocardial infarction during the COVID-19 pandemic...
Conference Coverage
Low-risk TAVR loses ground at 2 years in PARTNER 3
Conference Coverage
Radial arteries show CABG survival advantage over saphenous veins
For the first time, an arterial alternative to saphenous vein grafts produced a survival benefit when used as the second CABG conduit.
Conference Coverage
Outcomes-based measurement of TAVR program quality goes live
The ACC and STS team that runs the mandated U.S. national TAVR registry devised and is launching a new metric to measure program quality.
Conference Coverage
UK TAVI: Similar outcomes to surgery in real world
The trial confirms that the results of previous trials in low- to intermediate-risk patients can also be replicated in real-world clinical...
Conference Coverage
Novel mitral valve device shows encouraging mortality data
At 3 years, a novel annuloplasty device for mitral valve regurgitation is associated with low relative mortality.